This retrospective population-based cohort of patients on amiodarone assessed the incidence and presentation of amiodarone-associated neurotoxicity. They found 3% of patients on amiodarone experienced neurotoxicity, consisting of tremor, ataxia, peripheral neuropathy, and cognitive impairment. These correlated directly with duration of treatment, and was usually reversible with cessation of treatment (abstract).
Leave A Comment